Boston Scientific Issues Updates on Vessix Renal Denervation Studies

Boston Scientific touted its newly acquired Vessix Vascular renal denervation system, releasing interim reports from the REDUCE-HTN clinical trial during the Transcatheter Cardiovascular Therapeutics conference in San Francisco.
MassDevice